Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
John Han-Chih Chang, MD and Kenneth Blank, MD
Ultima Vez Modificado: 1 de noviembre del 2001
My husband and I are stationed in England. We just recently received information from back home that my mother has been diagnosed with stomach cancer. We are in the dark being so far away from home. Could you help us find information about this disease and what complications may arise? If you could lead us in the right direction, that would be greatly appreciated. Thank you ever so much.
John Han-Chih Chang, MD and Kenneth Blank, MD, Editorial Assistants for OncoLink, respond:
hank you for your interest and question.
Stomach or gastric cancer is the second most common cause of cancer death in the world, but it is not frequent entity in the United States. It has a higher incidence in Japan and other Asian countries. It is associated with diets high in nitrosamines or meat preservatives found in smoked or salted foods. It has also been linked to chronic atrophic gastritis.
The problem with gastric cancers is that they are usually diagnosed in more advanced stages, because early lesions are asymptomatic. Most have spread beyond the stomach to the regional lymph nodes or directly into the adjacent organs or structures. This would indicate a poor prognosis.
The mainstay of treatment at this time is radical surgery with removal of the primary gastric tumor with the entire stomach or part of it. This is reconnected with an anastamosis to the small bowels. Some advocate diagnostic and/or therapeutic extensive dissection of all regional lymph nodes. This technique has been supported strongly by the Japanese. Most believe, however, that this procedure does not improve outcome.
There have been studies that have revealed a 40% ? 80% local failure rate. This means that the tumor reappears in the operative bed and/or regional lymph nodes after surgery alone 40-80% of the time. Due to the possible lack of success with surgery alone, new avenues were pursued with adjuvant chemotherapy and/or radiation therapy post-operatively or definitively (for those who are not surgical candidates).
Randomized trials of treatment post surgery have revealed that chemotherapy alone patients fair worse than those that receive radiation combined with chemotherapy in improving loco-regional recurrence. However, minimal evidence has been demonstrated whether any of this helpful in survival improvement compared to surgery alone. In other words, it is preferable to spare the patient the possible side effects of radiation and/or chemotherapy until such time as that they need those treatments. This remains a very controversial issue with the significant studies having been performed by the gastrointestinal tumor study group and the Europeans.
There is a current national trial underway randomizing patients to adjuvant treatment post-operatively versus no further therapy. This trial's results may finally answer the question of the utility of adjuvant therapy in gastric cancer. There has been literature in support of using adjuvant therapy for poor prognostic indices such as positive lymph nodes and margins. Again, the jury is still out. Despite all the negative literature about adjuvant therapy, we believe in certain incidences that the loco-regional cancer control is essential to a significant quality of life.
As always, please discuss these issues with your mother's cancer physicians.
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults